发明名称 Compounds as tyrosine kinase modulators
摘要 The present invention is directed to novel compounds of Formula I. The compounds of the present invention are potent tyrosine kinase modulators, and are suitable for the treatment and prevention of diseases and conditions related to abnormal activities of tyrosine kinase receptors.;
申请公布号 US9475801(B2) 申请公布日期 2016.10.25
申请号 US201514793913 申请日期 2015.07.08
申请人 ALLERGAN, INC. 发明人 Guo Xialing;Zhu Zhen
分类号 C07D401/04;C07D405/14;A61K31/44;C07D413/14;C07D401/14;C07D409/04;C07D409/14;C07D405/00 主分类号 C07D401/04
代理机构 代理人 Bass Jonathan
主权项 1. A compound represented by Formula I: or a pharmaceutically acceptable salt thereof, wherein: X is NH;RI is selected from the group consisting of a is 0 or 1;RII is independently selected from the group consisting of hydrogen and NH2;b is 0 or an integer of from 1 to 2;Y is selected from the group consisting of  and a single bond;Ring A in the structure is phenyl;RIII represents optionally halogen;Z is selected from the group consisting of Ring B in the structure is selected from the group consisting of: (i′) phenyl;(ii′) thienyl; and(iii′) furoyl; andRIV represents optionally 1-3 substituents, independently selected from the group consisting of methyl and halogen.
地址 Irvine CA US